Carl Anthony Evans

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Houston, TX
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Christopher Downs, Attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Carl Anthony Evans

Form 4 holding Director

CNS Pharmaceuticals, Inc.

Security class
Restricted Stock Units
Shares / value
147,094
Estimated value
$44,128
Report date
08 Apr 2024
Price
$0.3000
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CNS Pharmaceuticals, Inc.

Security class
Common stock
Shares / value
33,458
Estimated value
$10,037
Report date
01 Feb 2024
Price
$0.3000
Ownership
Direct
Form 4 holding Director

CNS Pharmaceuticals, Inc.

Security class
Option to purchase common stock
Shares / value
129,594
Estimated value
Report date
08 Apr 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CNS Pharmaceuticals, Inc.

Security class
Series B Warrant to purchase common stock
Shares / value
112,094
Estimated value
Report date
01 Feb 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CNS Pharmaceuticals, Inc.

Security class
Series A Warrant to purchase common stock
Shares / value
78,761
Estimated value
Report date
01 Feb 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Carl Anthony Evans

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .